Page last updated: 2024-09-03

sr 48692 and Sarcoma

sr 48692 has been researched along with Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maeda, S; Nagano, S; Saitoh, Y; Sasaki, H; Setoguchi, T; Taniguchi, N; Tanimoto, A; Tokumoto, H	1

Other Studies

1 other study(ies) available for sr 48692 and Sarcoma

Article	Year
Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth. Molecular carcinogenesis, 2019, Volume: 58, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Panobinostat; Pyrazoles; Quinolines; Receptors, Neurotensin; Sarcoma; Up-Regulation; Xenograft Model Antitumor Assays	2019

Article

Year

Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.

Molecular carcinogenesis, 2019, Volume: 58, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Panobinostat; Pyrazoles; Quinolines; Receptors, Neurotensin; Sarcoma; Up-Regulation; Xenograft Model Antitumor Assays

2019